You just read:

BiondVax's Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season's Enrollment of 4,098 Participants

News provided by

BiondVax Pharmaceuticals Ltd.

Oct 24, 2018, 07:00 ET